Cognitive Behavioural Group Therapy Versus Individual Supportive Therapy for the Prevention of Repeat Suicide Attempts
NCT ID: NCT02664701
Last Updated: 2025-08-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
NA
240 participants
INTERVENTIONAL
2017-10-17
2025-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Community-Based Cognitive Therapy for Suicide Attempters
NCT00081367
The Cognitive-behavioral Approach, Standard Plan Security on Relapse Suicidal Adolescents
NCT02963870
Enhanced Brief CBT for Suicidal Inpatients With Mood Disorders
NCT07072845
An Initial Feasibility Study of Brief Cognitive Behavioral Therapy for Suicidal Inpatients
NCT03442699
Mindfulness-Based Cognitive Therapy + Safety Planning For Suicidal Behavior
NCT01826240
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
A. parameters describing the incidence of suicide and repeat suicide attempts, as well as suicide re-attempt free follow-up time,
B. long-term changes in suicidal ideation,
C. long-term changes in psychiatric symptoms (depression, hope for the future, hospitalization).
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Individual supportive therapy
Patients randomized to this arm will have individual supportive therapy.
Intervention: Baseline evaluation with a psychiatrist
Intervention: Individual supportive therapy
Intervention: Evaluations with a psychiatrist
Baseline evaluation with a psychiatrist
Baseline data and questionnaires are established.
Individual supportive therapy
6 sessions of individual supportive therapy with a psychologist, 1 session per week for 6 weeks
Evaluations with a psychiatrist
Evaluation withs a psychiatrist in the 10 days following the end of psychotherapy, then at 3, 6, 9, and 12 months.
Cognitive behavioural group therapy
Patients randomized to this arm will have cognitive behavioural therapy.
Intervention: Baseline evaluation with a psychiatrist
Intervention: Cognitive behavioural group therapy
Intervention: Evaluations with a psychiatrist
Baseline evaluation with a psychiatrist
Baseline data and questionnaires are established.
Cognitive behavioural group therapy
6 sessions of cognitive behavioural group therapy with a psychologist, 1 session per week for 6 weeks
Evaluations with a psychiatrist
Evaluation withs a psychiatrist in the 10 days following the end of psychotherapy, then at 3, 6, 9, and 12 months.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Baseline evaluation with a psychiatrist
Baseline data and questionnaires are established.
Individual supportive therapy
6 sessions of individual supportive therapy with a psychologist, 1 session per week for 6 weeks
Cognitive behavioural group therapy
6 sessions of cognitive behavioural group therapy with a psychologist, 1 session per week for 6 weeks
Evaluations with a psychiatrist
Evaluation withs a psychiatrist in the 10 days following the end of psychotherapy, then at 3, 6, 9, and 12 months.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* The patient must have given his/her informed and signed consent
* The patient must be insured or beneficiary of a health insurance plan
* French speaking adults (18 years or older) freely hospitalized (in centres or via emergency services) for prevention of suicide and who have a medium or high suicide risk score according to a Mini International Neuropsychiatric Interview structured interview
* Presence of suicidal ideation according to the Beck Suicide Ideation Scale (score \> 3)
* Prior (or recent) suicide attempt within the last three month
* The patient is able to understand the study and capable of giving his/her informed consent
* The patient is available during the weekly time slots proposed by the investigator
Exclusion Criteria
* Within the past three months, the patient has participated in another study that may interfere with the results or conclusions of this study
* The patient is in an exclusion period determined by a previous study
* The patient is under judicial protection, or is an adult under guardianship
* The patient refuses to sign the consent, or it is impossible to correctly inform the patient
* Emergency situations preventing proper study conduct
* History of schizophrenia or other psychotic troubles
* Presence of psychotic symptoms at initial interview
* Serious cognitive impairment
* Medical incapacity to participate
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Hospitalier Universitaire de Nīmes
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mocrane Abbar, MD
Role: STUDY_DIRECTOR
Centre Hospitalier Universitaire de Nîmes
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU de Clermont Ferrand - Hôpital Gabriel-Montpied
Clermont-Ferrand, , France
CHU de Lyon - Groupement Hospitalier Edouard Herriot
Lyon, , France
CHRU de Montpellier - Hôpital Lapeyronie
Montpellier, , France
Clinique Les Sophoras
Nîmes, , France
CHRU de Nîmes - Hôpital Universitaire Carémeau
Nîmes, , France
CMME
Paris, , France
CH Henri Laborit
Poitiers, , France
CHRU de Tours - Clinique Psychiatrique Universitaire
Saint-Cyr-sur-Loire, , France
CHRU de Strasbourg - Hôpital Civil
Strasbourg, , France
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Witt KG, Hetrick SE, Rajaram G, Hazell P, Taylor Salisbury TL, Townsend E, Hawton K. Psychosocial interventions for self-harm in adults. Cochrane Database Syst Rev. 2021 Apr 22;4(4):CD013668. doi: 10.1002/14651858.CD013668.pub2.
Chaib LS, Lopez-Castroman J, Abbar M. Group Post-Admission Cognitive Therapy for Suicidality vs Individual Supportive Therapy for the prevention of repeat suicide attempts: a randomized controlled trial. Trials. 2020 Oct 27;21(1):889. doi: 10.1186/s13063-020-04816-y.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2015-A01585-44
Identifier Type: OTHER
Identifier Source: secondary_id
PHRC-N/2014/MA-01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.